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Abstract 
Recently, gluten free foods have attracted much research interest motivated by the increasing 
market. Despite the motivation for developing gluten-free foods it is necessary to have a 
scientific basis for developing gluten-free foods and the tools for detecting the peptide 
sequence that could be immune-toxic to some persons. This review will be focused primarily 
on the cereal-based commodities available for developing gluten free blends, considering 
those naturally gluten free cereals besides the controversial oats, and the recent transgenic 
approaches for developing cereals free of immunotoxic gluten. Secondly, the biochemical 
tools for mimicking gluten network viscoelastic properties will be presented. Finally, special 
emphasis will be put in compiling the available techniques for gluten detection and 
quantitation. 
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1. Introduction 
Wheat, barley and rye are temperate cultivated cereals from the grass tribe triticeae. These 
cereals are major suppliers of calories to the human diet as the main component of the grain is 
starch. They also contain 8-15% of protein, which mainly correspond to the gluten proteins. 
Those proteins are important because of their impact on grain processing properties, for the 
production of bread, pasta and noodles from wheat, and for malting, brewing and distilling of 
barley. Gluten is a complex mixture of proteins comprising the gliadins and glutenins in 
wheat and equivalent proteins in barley and rye, representing 80% of total grain proteins. 
However, gluten proteins also have negative impacts on human health, in relation to allergies 
and intolerances. Gluten is defined differently depending on the discipline (biochemistry, 
food technology, nutrition). In the gluten-free intolerance context the most appropriate 
definition is that provided by the European Commission where gluten means a protein 
fraction from wheat, rye, barley, oats or their crossbred varieties and derivatives thereof, to 
which some persons are intolerant and which is insoluble in water and 0.5 M sodium chloride 
solution (Commission of the European Communities, 2009). 
In recent decades, gluten has attracted great attention due to the increasing number of 
diagnosed patients with intolerance to this protein fraction, relating to the improved 
sensitivity of the detection methods and the increasing awareness of the existence of the 
disease. Three pathologies are associated with gluten intake (Figure 1), which appear to be 
increasing in importance: i) food allergy that affects 0.2-0.5% of the population but has 
stronger clinical implications (Zuidmeer et al., 2008), ii) coeliac disease (CD), which is an 
autoimmune disorder caused by the ingestion of gluten not only from wheat, but also rye, 
barley and some varieties of oats (Comino et al., 2011) affects both children and adults 
throughout the world at various frequencies (from 0.1% to >1.6%), specifically 1% of the 
Werstern world (Abadie et al., 2011), and iii) gluten sensitivity, a pathology of intolerance to 
gluten that has been recently rediscovered (Sapone et al., 2011), which excludes CD and 
wheat allergy, with an estimated prevalence of 6% for the USA population.  
There is evidence that there are peptides that are responsible for celiac disease and gluten 
allergy. However, the intolerance's and non-celiac gluten sensitivity have been related to other 
components present in bread. Much research has been focused on determining the peptide 
sequence promoting bowel inflammation, although very much remains unknown. CD is an 
inflammatory disease of the upper small intestine caused by glutamine- and proline-rich 
peptides from cereal storage proteins (gluten) with a minimal length of nine amino acids, but 
innate immunity is also involved in the damage produced by these cereals (Bernardo et al., 
2012). In people with a genetic susceptibility, such peptides are insufficiently degraded by 
gastrointestinal enzymes; they permeate the lymphatic tissue, are bound to celiac-specific, 
antigen-presenting cells, and stimulate intestinal T-cells. Till now, the only effective therapy 
is based on a gluten-free diet (GFD) long-life, which explains the interest in developing safe, 
nutritionally balanced and palatable gluten free foods. This poses challenges for the use of 
cereals to develop gluten free-products. Nevertheless, this challenge has been met by 
agronomic and food technology approaches, which will be discussed in the next sections. This 
review will be focused on cereal-based commodities available for developing gluten-free 
blends and the biochemical tools for mimicking gluten network viscoelastic properties. 
Special emphasis will be put on describing the available techniques for gluten detection and 
quantitation.  
2. Gluten free cereals  
2.1 Cereals reported to be gluten free 
Although the name wheat is always associated with gluten and with toxicity for coeliac 
patients, some reports have stated that some wheat cultivars are safe for this population. In 
fact, Spaenij-Dekking et al. (2005) investigated whether wheat varieties exist with a natural 
low number of T-cell-stimulatory epitopes by analysing gluten protein sequences present in 
public databases. In their study, wheat accessions from diploid (AA, SS/BB, and DD 
genomes), tetraploid (AABB), and hexaploid (AABBDD) Triticum species were also tested 
for the presence of T-cell-stimulatory epitopes in gliadins and glutenins by both T-cell and 
monoclonal antibody-based assays. The authors identified gluten proteins that lack one or 
more of the known T-cell-stimulatory sequences suggesting that it would be possible to select 
and breed wheat varieties that contain low amounts of T-cell-stimulatory sequences. One 
example is Triticum monococcum, the oldest and most primitive cultivated wheat. Pizzuti et 
al. (2006) evaluated the toxicity of this wheat by using an in vitro distal duodenum biopsies 
culture system, which were subjected to conventional histological examination and 
immunohistochemical detection. This revealed that T. monococcum gliadin shows a lack of 
toxicity. 
Cereals that are always considered gluten free are rice (Oryza sativa L.), maize (Zea mays L.) 
and sorghum (Sorghum bicolor (L.) Moench), which are distant relatives of wheat and are 
known to be safe for coeliacs. In addition, a number of species of  millets, the Ethiopian 
cereal teff, and a range of pseudocereals are also available for providing gluten free flours, 
even increasing the nutritional pattern of those products in the case of pseudocereals (Alvarez-
Jubete et al., 2010). Nevertheless, rice and corn are low in protein, fibre, and folate (Table 1); 
whereas teff, quinoa, amaranth and buckwheat show a favourable fatty acid composition and 
they are high in protein (Hager et al., 2012). In particular, amaranth and teff are high in 
calcium, magnesium and iron, although those contents are greatly dependent on the region of 
cultivation.  
Rice flour is the most suitable commodity for bakery applications due to its bland taste, white 
colour, digestibility and hypoallergenic properties. Other attributes such as the low content of 
protein and sodium and the presence of easily digested carbohydrates are additional benefits. 
In rice, the ratio of albumin-globulin-prolamin-glutelin is unique among the cereals, having a 
high concentration of glutelins and low prolamins prolamins (Hamaker, 1994). As in the other 
cereals, rice proteins are deficient in essential amino acid lysine, but as a consequence of the 
ratio of protein fractions, rice has higher content of lysine than the other cereals, which is 
shared by oats. It is important to note that although the amino acid pattern of the proteins 
could be similar in different rice varieties, significant differences have been reported in 
protein and starch digestibility among varieties (Acquistucci et al., 2009).  
Immunochemical, molecular and in vitro and in vivo studies support the conclusion that 
sorghum does not contain peptides that are toxic for coeliac patients. The analysis of 
aqueous/alcohol-soluble prolamins (kafirins) from different sorghum varieties provides 
molecular evidence for the absence of toxic gliadin-like peptides in sorghum (Pontieri et al., 
2013). A similar study carried out with amaranth revealed that all of the amaranth samples 
studied showed similar binding affinities for both specific anti-gliadin antibodies and human 
IgAs, and the molecular characterisation of amaranth proteins suggests that it is safe for 
coeliacs to consume (Ballabio et al., 2011). 
Teff, a low risk cereal for coeliacs that is grown in Ethiopa and other countries, has an 
excellent amino acid composition (including all 8 essential amino acids for humans), very 
high fibre content and high nutrient content in general, being suitable for gluten-free 
applications (Gebremariam et al., 2012). 
2.2 The oats controversy: selection of oat varieties with no toxicity in coeliac disease 
There is an on-going debate concerning the presence or absence of proteins in oats that could 
be toxic for coeliac patients. Traditionally, treatment with a gluten free diet GFD has excluded 
not only wheat, barley, and rye, but also oats. Oats, like rice, differs from other cereals in their 
prolamin content. The percentage of proline and glutamine (amino acids abundant in toxic 
regions) in avenins is lower than in prolamins from toxic cereals (Figure 2). However, there is 
still some debate about the safety of oats (Pulido et al., 2009). Several in vivo and in vitro 
studies have indicated that the majority of coeliac subjects could tolerate moderate amounts of 
pure oats. Some countries permit the use of oats in gluten-free products, e.g. Gluten Free 
Oats®. According to the Codex Alimentarius Commission (2008), oats can be tolerated by 
most, but not all, people who are gluten-intolerant. Therefore, the acceptance of oats that are 
not contaminated with wheat, rye, or barley in foods covered by this standard may be 
determined at the national level. Moreover, according to the Commission of the European 
Communities (2009), a major concern is the contamination of oats with wheat, rye, or barley 
that can occur during grain harvesting, transport, storage, and processing. Therefore, the risk 
of gluten contamination in products containing oats should be taken into consideration with 
regard to labelling of products. Some cross-reactivity with gliadin-specific antibody has been 
attributed to wheat contamination in oat-based food (Pulido et al., 2009).
However, other authors have reported clear evidence suggesting that avenins have the ability 
to induce the activation of mucosal T-cells, causing gut inflammation and villous atrophy 
(Pulido et al., 2009). Arentz-Hansen et al. (2004) described the intestinal deterioration 
suffered by some CD patients following the consumption of oats while on gluten free diet. 
Avenins can trigger an immunological response in these patients similar to the response 
produced by the gluten of wheat, rye, or barley. The monitoring of 19 adult coeliac patients 
who consumed 50 g/day of oats over twelve weeks showed that one of the subjects was 
sensitive to oats. Therefore, it is critical to clarify either qualitatively or quantitatively the 
potential immunotoxicity of oats to coeliac patients (Arentz-Hansen et al., 2004; Pulido et al., 
2009).  
Comino et al. (2011) showed using the anti-33-mer antibodies (G12 and A1) raised against 
the toxic fragment that oat immunogenicity for CD patients varies according to the cultivar. 
The intensity of the signal obtained with the antibody was proportional to the potential 
damage caused to CD patients, thereby providing a rational explanation of why some oats 
trigger immunological response, and a solution to avoid the presence of such varieties in 
gluten-free diets.  
3. Transgenic approaches for developing cereals free of immunotoxic gluten 
The identification and/or breeding of wheat cultivars or close relatives naturally deficient in 
immunogenic prolamins is very appealing. However, none of the tested materials (including 
landraces, cultivars, and deletion lines) was completely nontoxic for CD patients (Spaenij 
Dekking et al., 2005; van den Broeck et al., 2009; Comino et al., 2012a). The high level of 
complexity of gliadin genes and the fact that they may contain multiple and different T-cell 
epitopes (van Herpen et al., 2006), make conventional breeding approaches to obtain wheat 
varieties with reduced content of immunotoxic sequences very difficult. 
The use of genetic engineering to down-regulate gene expression is now routinely used in 
many crops, including all the major cereals, and is therefore an attractive opportunity for 
reducing the immunotoxic components of gluten and, therefore the incidence of gluten-related 
allergies and intolerance in cereals. Most of the examples listed below of down-regulation of 
gluten proteins in wheat and other cereals are based on RNA interference (RNAi) technology 
(Table 1). Although not all of them were specifically aimed to develop low-gluten cereals for 
human allergies and intolerance, they prove that the down-regulation of the different gluten 
fractions related to the CD can be achieved using this technology.  
RNA silencing is a sequence-specific RNA degradation system that is conserved in a wide 
range of organisms, and termed post-transcriptional gene silencing and RNAi, in plants and 
animals, respectively. RNAi is a post-transcriptional process triggered by double-stranded 
RNA (dsRNA), which leads to gene silencing via a two-step mechanism (Watanabe, 2011).  
Becker et al. (2006) reported the use of hpRNA constructs to knock down the a-gliadins in cv 
Florida. They produced a range of transgenic plants with the -gliadins silenced. Flours from 
transgenic and wild type lines were analysed by RP-HPLC, showing a 63% reduction of the 
a-gliadins in the transgenic lines (Becker et al., 2012) (Table 1). The loss of a-gliadins was 
compensated by the increase of albumins/globulins (34%), -gliadins (23%), -gliadins 
(20%), HMW-GS (16%) and glutenin-bound -gliadins (8%). In contrast, LMW-GS were not 
affected. Overall, the total contents of gliadins and gluten were reduced, respectively, by 16 
and 9%. Interestingly, the crude protein content was similar in transgenic lines and in the wild 
type. 
Lange et al. (2007) introduced an antisense construct against C-hordeins (the sulphur-poor 
storage proteins of barley which are homologous to the -gliadins of wheat) into barley cv 
'Golden Promise'. The reduction of the target proteins ranged from 29 to 40% depending on 
the transgenic line. Other storage proteins were affected by the down-regulation of C-
hordeins; the relative amount of /B-hordeins was increased in the transgenic lines while there 
were also minor relative increases in the amounts of D-hordeins (homologous to the HMW-
GS of wheat). The increase in the sulphur-rich /B-hordeins and D-hordeins was related to 
significant higher expression levels of the corresponding genes (Hansen et al., 2007). 
Interestingly, this re-distribution in the proportions of storage proteins resulted in a more 
balanced amino acid composition; the five antisense lines had lower amounts of proline, 
glutamic acid/glutamine, and phenylalanine (up to 12%, 6%, and 9% reduction), while the 
lysine, threonine, and methionine contents were increased by up to 16%, 13% and 11%, 
respectively. 
Gil-Humanes et al. (2008) and Piston et al. (2011) also used two hpRNA constructs to silence 
the -gliadins in two genotypes of the bread wheat cv Bobwhite. They reported 18 
transgenic lines with reductions in the -gliadin fraction. However, the down-regulation was 
variable, ranging from 65 to 97% depending of the transgenic line (Piston et al., 2011). The 
reduction of -gliadins was also accompanied by an increase in other storage proteins, in 
particular, the - and -gliadins (Table 2). However, the total gliadin content did not differ 
significantly in the transgenic lines relative to the wild type. Likewise, the transgenic lines 
showed increases in the HMW-GS, LMW-GS and total glutenin contents. Overall, the gluten 
content was increased by an average of 50% and the total protein content was slightly higher 
in most of transgenic lines, but more significantly for lines of one of the genotypes. They 
carried out an in silico analysis of the amino acid composition of gluten proteins in transgenic 
lines with down-regulated -gliadins and control lines, showing that the overall proportions of 
amino acids were not significantly modified in the transgenic lines relative to the wild type 
(Piston et al., 2011). 
The -gliadin fraction has also been targeted for silencing by RNAi (Altenbach and Allen, 
2011). Analysis of proteins in grain from transgenic plants demonstrated that the 5-gliadins 
were either absent or substantially reduced relative to the amounts in non-transformed 
controls while other gliadins, including -gliadins from genomes A and D, were not affected. 
The effects of silencing of 5-gliadin on other gluten or non-gluten proteins were not 
reported. 
Several groups have taken advantage of the possibilities that the RNAi technology offers for 
the silencing of multigene families, and have also addressed the down-regulation of more than 
one group of gliadins and/or glutenins. 
Gil-Humanes et al. (2010) reported two hpRNA constructs designed using a chimeric 
fragment of 361 bp, encompassing sequences highly conserved among -, -, and -gliadins. 
They used both hpRNA constructs, single or in combination, to produce a range of transgenic 
plants from two genotypes of the bread wheat cv Bobwhite. They showed that the chimeric 
fragment was able to effectively down-regulate the expression of genes from all three gliadin 
groups. Interestingly, one line (BW2003) was found to carry the translocation T1BL.1RS and 
expressing the -secalins from rye, which were also silenced by the chimeric fragment (Gil-
Humanes et al., 2010). The gliadin composition, determined by RP-HPLC, showed a 
significant reduction in the gliadin content in all of the transgenic lines, ranging from 70 and 
88%. The down-regulation of gliadins also resulted in changes in other grain proteins. The 
HMW-GS were increased in some transgenic lines compared with wild types. In contrast, the 
LMW-GS were unaffected in most of the lines, and only four lines showed a significant 
decreased in the LMW-GS content relative to the wild-type line. Overall, the gluten proteins 
were decreased by up to 56% while the non-gluten proteins albumins and globulins were 
increased in some transgenic lines (Gil-Humanes et al., 2011), as consequence, the total 
nitrogen content of the grain was not significantly affected.  
A different approach was followed by Wen et al. (2012) to down-regulate gliadins and LMW-
GS in wheat. They reported the transcriptional suppression of wheat DEMETER (DME) 
homologs using RNA interference in the bread wheat cv Brundage 96 (Wen et al. 2012). 
The results of qRT-PCR showed suppression in DME transcript abundance ranging from 3.0 
to 85.2% in different transgenic plants. The level of reduction of LMW-GS and gliadins based 
on the HPLC chromatograms ranged from 45.2 to 76.4%, depending of the transgenic line. 
However, not all gliadin and glutenin fractions were equally affected, and the transgenic lines 
showed different profiles of elimination and/or reduction of specific gliadin and/or glutenin 
family members. In most of the transgenic lines all three gliadin fractions and LMW-GS were 
down-regulated, and HMW-GS were likewise slightly decreased. They also reported lines in 
which a slight increase in the amount of -gliadins and a significant increase in the amount of 
HMW-GS was also observed (Wen et al., 2012).  
3.1 Effects of RNAi silencing on baking properties and immunotoxicity  
In all the above examples, the silencing of a given gliadin fraction is compensated by an 
increase in another group of gliadins, glutenin subunits or even albumins/globulins, so that the 
total content of gliadins and/or gluten in the grain is not greatly affected. There are two 
important points to consider: 1) how quality is affected by the silencing of gliadins, or other 
gluten proteins, and 2) whether the deficiency of these gluten fractions results in an effective 
reduction of immunotoxicity for the transgenic lines to be used in foodstuff tolerated by many 
patients with CD or other gluten-related pathologies. 
Becker et al. (2012) reported the rheological and gluten properties, and baking quality of 
wheat lines with reduced -gliadin content. Due to the strong reduction in -gliadins and the 
lower ratio of gliadins to glutenins, the rheological properties of glutens from the transgenic 
flour and the wild type flour differed strongly. In contrast, the rheological properties of the 
doughs were almost identical. They also showed that the deficiency of -gliadins did not 
substantially affect the baking performance of wheat flour, although breads made using flour 
from lines with silenced -gliadins had lower volumes (-11%) compared to those of wild type 
breads (Wieser et al., 2006). Piston et al. (2011) determined the mixing properties of 18 
transgenic lines from two genotypes with the down-regulated -gliadins by using the 
mixograph and sodium dodecyl sulphate sedimentation (SDSS) test. They showed that most 
of the parameters were not affected by the down-regulation of the -gliadins, and only peak 
width (PW1), mixing time (MT), and SDSS volumes were affected in some lines. These 
observations were later confirmed by the introgression of the silencing of -gliadins into 
commercial lines of bread wheat (Gil-Humanes et al., 2012). They concluded that the 
reduction of -gliadins seems not to have a direct effect on the mixing and bread-making 
properties of wheat dough, but the compensatory effect on the synthesis of the other 
prolamins can provide stronger doughs with improved resistance to overmixing. It is not 
known whether the silencing of all three groups of gliadins (Gil-Humanes et al., 2010), or 
gliadins and LMW-GS (Wen et al., 2012) will have effects on wheat quality. Preliminary 
results were reported by (Gil-Humanes et al., 2010) based on the SDSS test. They showed that 
most of transgenic lines with down-regulated -, - and -gliadins had SDSS volumes 
comparable with those of wild type lines, and five lines had SDSS volumess significantly 
lower than those of wild type lines. However, the SDSS volumes of these five lines were still 
comparable with those of the medium-quality bread wheat. 
The transgenic lines described above are deficient in one or more groups of gluten proteins 
(-, -, -gliadins and glutenin subunits), which are the known sources of immunogenic 
epitopes. Thus, these lines themselves hold good potential to be tested for immunotoxicity by 
monoclonal antibodies and T-cell assays. At present, only transgenic lines deficient in -
gliadins (Gil-Humanes et al., 2008) and in all three gliadin fractions (Gil-Humanes et al., 
2010) have been tested by monoclonal antibodies and T-cell assays. They reported that for 
transgenic lines with silenced -gliadins, the gliadin content (ppm) did not decrease 
significantly but increased for some lines as consequence of the compensatory effects on 
other gliadins, specifically on - and -gliadins (Gil-Humanes et al., 2008; 2010). However, 
when gluten proteins from transgenic lines deficient in all three groups of gliadins were 
tested, there was a significant reduction in the gliadin content in all of the transgenic lines, 
with an average reduction of 92.2% and a range between 89.7% and 98.1% (Gil-Humanes et 
al., 2010).  
According to the Codex Alimentarius standard for gluten-free food the gliadin content is 
taken as 50% of gluten so that the gluten content has to be calculated by multiplying the 
gliadin content by a factor of 2. The gluten content was calculated (Table 3) for lines reported 
by Gil-Humanes et al. (2010) and the predicted tolerable daily intake of gluten estimated on 
the basis of results by Catassi et al. (2007). In this study, a daily intake of 50 mg gluten was 
established as the maximum dose in order to avoid damage to the small intestine of CD 
patients during a prolonged exposure of 90 days. This means that for the wild type lines the 
tolerated amount of flour would be less than 0.4 g (Table 3). However, for the line E82 a 
coeliac individual could safely ingest around 20.4 g per day of flour, and for line D793 the 
tolerated amount would be of up to 10.7 g. This amount of gluten could be reduced even more 
by mixing flour from the transgenic lines with flours from non-toxic cereals such as rice or 
corn. 
Acceptance of transgenic plants, as raw material for food depends upon the advantages of 
these crops are clearly perceived by the end consumers. Until now, GM crops commercialized 
mainly offer pest or herbicide resistance, for which the end consumer benefits are not 
obvious. For consumers, large companies and/or farmers, are the major beneficiaries of GM 
crops, and the benefit that they may have on agriculture and the environment is very diluted 
as a result of heavy campaigning by anti-GMO groups in developed countries. The 
development of wheat lines suitable for coeliacs and other gluten intolerances could be a 
major turning point: it aims to solve a health problem that directly affects a large proportion 
of consumers, also in developed countries, and with which the other consumers are very 
sensitive. 
4. Leavened Gluten free products: challenges for miming gluten 
Gluten free diets are characterised by an unbalanced intake of different nutrients, with very 
low contributions to the recommended daily protein intake, and high contributions to the 
carbohydrate and fat dietary reference intake (Matos and Rosell 2011). This highlights the 
importance of designing nutritionally balance or enriched gluten free products. Recently, 
gluten-free foods have been the subject of massive research motivated by three global trends: 
the increased number of coeliac patients, which is related to the enhanced sensitivity of the 
detection techniques, the market trends because gluten free foodstuffs are viewed as a niche 
market for expansion, and the association between gluten-free foods and health living. 
Irrespective of the motivation for developing gluten-free foodstuffs it is necessary to have a 
scientific basis for developing gluten free foods, which has been a very active area of 
research. Recently, Zannini et al. (2013) reviewed the technological challenges and strategies 
for developing gluten-free bread and the importance of foodomics studies (comprising 
genomics, proteomics, metabolomics and materiomics) to overcome the limitations due to the 
inability of gluten-free cereal flours to retain carbon dioxide in fermented products. As a 
consequence, the addition of different components, by different flour and dough treatments or 
by changing the method of baking is required to improve quality in gluten-free bread 
production (Houben et al., 2012).  
The functional properties of cereals and cereal-based flours play a major role when 
developing fermented gluten-free products. For instance, the type of rice milling and the 
resulting particle size of the flour define the suitability of the rice or corn flours for 
breadmaking (Song and Shin, 2007; Brites et al., 2010). Particle size fractionation of rice 
flour may be advisable for selecting specific physico-chemical properties (De la Hera et al., 
2013). In fact, De la Hera et al (2012) stated that coarser corn flours (>180 m) provide 
breads with higher volume and softer crumb due to their ability to retain carbon dioxide 
during proofing. Considering the thermal properties, it has been reported that initial pasting 
and setback viscosities decrease with decreasing particle sizes, with wet milled rice flours that 
have higher apparent viscosity and smaller particle sizes than dry-milled rice flour showing 
better properties for making gluten-free rice bread (Song and Shin, 2007). Rice cultivars with 
intermediate amylose contents, which also are sticky and soft, give bread with high volume 
(Iwashita et al., 2011). In addition to the cultivar type, germination is also of interest for 
increasing the nutritional pattern of cereals and pseudocereals (Omary et al., 2012) and 
because proteolytic enzymes produced during germination could decrease the toxicity of 
some cereals. A concrete example is the hydrolysis of rye secalin peptides by cereal enzymes 
from germinating barley. These released short fragments and reduced the toxicity of the rye 
(Stenman et al., 2010).   
Nevertheless, some additional structuring agents are always necessary to counteract the lack 
of viscoelasticity associated with the absence of gluten. Leaving aside the addition of 
structuring ingredients (hydrocolloids, proteins, and so on), which has been a very active area 
of research, and without trying to be exhaustive, some attempts to create internal networks in 
cereal flours are discussed. Oxidizing or crosslinking enzymes have proved to be good 
alternatives for improving dough performance and the quality of the gluten-free breads. For 
example, the addition of cyclodextrin glycosyl transferase to the rice bread formulation led to 
rice loaves with very soft crumb and extended the shelf life (Gujral et al., 2003a, b). Other 
useful enzymes in rice bread formulation are glucose oxidase and transglutaminase (Gujral et 
al., 2004a, b) that catalyse the formation of inter and intramolecular crosslinks between the 
cereal proteins leading to a protein network (Marco and Rosell 2007, 2008). Protein 
crosslinking catalysed by transglutaminase was confirmed by the decrease in the amount of 
free amino groups and the disappearance of numerous protein bands as a consequence of the 
formation of large protein polymers, linked by isopeptidic and disulphide bonds, with reduced 
solubility (Marco et al., 2007).  
Numerous alternatives have been reported recently to improve nutritionally gluten free 
products; it is not the intention of this review to list all of them, only to point out the most 
significant ones. The use of whole grains mainly to increase the fibre content or the addition 
of bran has been proposed to improve the nutrient profile of gluten-free products (Sairam et 
al., 2011). Making blends of cereal and pseudocereal flours such as buckwheat flour may give 
to gluten-free breads with enhanced contents of total phenolic compounds, rutin and quercetin 
contents and antioxidant activity (Sakac et al., 2011). Pregerminated brown rice is another 
alternative bread ingredient because it is more nutritious after germination with increased free 
gamma amino butyric acid (Charoenthaikij et al., 2010; 2012). 
5. Gluten analysis
 Gluten may trigger immune responses of different kinds in predisposed individuals. Since the 
only effective treatment is the avoidance of gluten containing foods, it is necessary to have 
reliable methods for gluten determination. Gluten proteins have unique compositions with 
approximately 15% proline and 35% glutamine residues (Alaedini and Green, 2005). 
Although most dietary proteins are digested into simple amino acids, dipeptides, and 
tripeptides by gastrointestinal proteases, the high content of proline residues makes the gluten 
peptides resistant to degradation by digestive proteases (Bethune and Khosla, 2008; Fasano, 
2009). About 10% of gluten appears to be made up of potentially toxic gliadin peptides 
(Khosla et al., 2005), thus it is desirable to quantify the amounts of these peptides, so that the 
toxicity of the gluten present in foods can be established more precisely. Nevertheless, 
Although - and gliadin-derived peptides are immunodominant in adults, responses to the 
LMW glutenins and -gliadins have been frequently observed in children and occasionally in 
adults (van de Wal et al., 1999; Vader et al, 2002). 
The presence of the numerous gluten components, the variation in the extraction efficiency, 
and the lack of reference materials are some issues that hinder the implementation of 
equivalent laws at national level and the comparison of data across the different methods 
(Diaz-Amigo et al., 2012).  
5.1. Factors affecting gluten analysis 
Proteins are modified to improve their functionally and increase their usage in different 
applications to form and stabilise structures. Proteins can be modified in various ways as 
deamidation, transamidation and degradation. All of these modifications can also happen 
naturally due to enzymes in cereal seeds. 
Hydrolysis is widely used in the preparation of wheat products in the food industry. 
Hydrolysis may decrease the toxicity of gluten (Greco et al., 2011) but also the fragmentation 
of peptides can make it more difficult to analyse gluten in these foods (Mena et al., 2012). 
Deamidation of gluten proteins is a widely used process in the food industry that leads to 
increased charge density on the protein, causing changes in protein conformation due to 
electrostatic repulsion. The analysis of deamidated gluten is more difficult as there is a 
decrease in the affinity and recognition of antibodies to gluten proteins and peptides, which 
may lead to underestimation when immunoassays are used to the quantify gluten content of 
foods (Kanerva et al., 2011).  
An important factor in prolamin and glutelin analysis is complete extraction from the samples. 
The extraction of gluten from wheat, barley, rye and oat standards is easier than from 
processed foods. During the processing of some foods, proteins are treated at high 
temperatures in a dry state at a neutral pH, forming isopeptide bonds between the -amino 
groups of lysine and the - or -carboxamide groups of asparagine and glutamine residues. 
Furthermore, the heat-treatment of cooked and baked products leads to the formation of 
protein aggregates in an insoluble matrix that makes analyses even more difficult. Therefore it 
is necessary to use an extraction system giving complete recovery of both prolamins and 
glutelins, to guarantee that products marketed as suitable for coeliacs are really gluten-free.  
The so-called cocktail solution combines reducing and disaggregating agents to extract gluten 
proteins completely as this ensures that protein aggregates are disrupted. (Garcia et al., 2005). 
However, it is not compatible with all the techniques used for gluten analysis because -
mercaptoethanol interferes with the specific binding of the antibodies used in some types of 
immunoassays, giving false results. More recently, another combination of reagents called 
UPEX (universal prolamin and glutelin extractant solution) leads to a complete extraction and 
it is compatible with all gluten analysis procedures (Mena et al., 2012). This solution includes 
the odourless reducing agent, Tris (2-carboxyethyl)-phosphine (TCEP) that is more specific 
for breaking disulphide bridges and less toxic than the other reducing agents commonly used 
(Han, 1999) and the disaggregating agent N-Lauroylsarcosine, widely used in plant cell lysis, 
which contributes to opening polypeptide chains and is even more efficient than guanidine 
hydrochloride (Schlink and Reski, 2002).  
In addition, a novel universal gluten extraction solution (UGES) has recently been described 
(Biomedal Diagnostics, Seville, Spain). The components of this gluten extraction solution are 
a reducing agent, a solubilising agent (arginine) and an antiseptic agent in ethanolic solution 
(patent WO 201231612; Muñoz-Ruano et al., manuscript in preparation). The UGES 
procedure gave high extraction efficiency from both simple and complex matrices even if they 
had heat-processed. 
Another of the critical points in gluten analysis is the use of a correct standard. This standard 
should be as representative as possible of the gluten proteins to be analysed. The Working 
Group on Prolamin Analysis and Toxicity (PWG) gliadin standard is the standard most used 
internationally for gluten analysis. This standard is obtained from a mixture of  28 wheat 
cultivars representative of the European wheat-producing countries (van Eckert et al., 2006). 
Nevertheless, cereals contain a greater number of proteins than those present in the PWG 
standard. Some authors have suggested that it would be more correct to use a hydrolysed 
standard combined with a competitive assay to quantify peptides of partially hydrolysed 
gluten in fermented wheat, rye, and barley products (Gessendorfer et al., 2009). Commercial 
foods usually have only partial hydrolysis and, when the proteins are exhaustively hydrolysed, 
the toxicity for coeliac patients of the peptides generated usually disappears (Stepniak et al., 
2006). Comparing the intact PWG gliadin standard with a partially enzimatically digested 
gliadin standard it has been demonstrated that the resulting curves are similar in each case 
when applying a competitive immunoassay and therefore the intact PWG gliadin standard can 
be used as a more accessible gold standard as it is more difficult to perform a reproducible 
hydrolysed standard (Mena et al., 2012). However, other strategies based on the use of 
immunotoxic peptides of gluten as standard are being developed for the analysis of samples 
with gluten hydrolysate This standard presented a high degree of repeatability, reproducibility 
and stability and the results obtained were correlated with the potential relative 
immunotoxicity of gluten (Comino et al., 2012b; 2013). 
5.2. Immunological techniques 
Many methods for detecting prolamin proteins have been developed over the years. The 
complexity of prolamin proteins, however, creates an enormous challenge in accurately 
quantifying the total prolamin content. Some methods including the polymerase chain 
reaction (PCR), HPLC and MS, may be used simultaneously with immunological methods. 
One of the most recent methods developed for gluten analysis is a potentiometric electronic 
tongue, which was able to detect 1-2 mg/Kg of gliadin from different matrices (Peres et al., 
2011). The most practical methods for food analysis is based on immunological analysis. An 
ideal antibody for gluten analysis in foods should be not only a reliable indicator of the 
presence of prolamins from cereal species known to be toxic to CD patients but also should 
recognise the specific intramolecular regions responsible for such toxicity. Nevertheless, there 
are many such regions and even today not all have been identified. 
5.2.1. Antibodies testing for gluten-free foods 
Several antibodies (Ab) have been raised against different prolamin epitopes. The anti -
gliadin Ab is used in a sandwich format that was approved as an official method by AOAC 
(Association of Official Agricultural Chemist, Skerrit and Hill, 1990, 1991). Other antibodies 
were raised against different epitopes of -gliadin, such as PN3 (residues 31-49) for the toxic 
19-mer peptides (Sturgess et al., 1994; Ellis et al., 1998), CD5 (residues 51-75), Abs against 
T-cell stimulatory peptides present in gluten (Mitea et al., 2008), and R5 which recognises 
highly repeated peptide sequences present in wheat, barley and rye grains. This antibody is a 
monoclonal antibody (Valdés et al., 2003; Mendez et al., 2005) that reacts with the epitope 
QQPFP and other  motifs such as QLPFP, LQPFP, and QQQFP present in coeliac-toxic 
sequences that occur repeatedly in gliadins, hordeins, and secalins being highly sensitive 
towards these prolamins (Valdes et al., 2003). 
Recent reports recommend updating the concept of gluten detection to potential relative 
immunotoxicity of gluten for the safety of coeliac consumers. Two monoclonal antibodies, 
G12 and A1 (anti-3-mer antibodies), were raised against the main immunogenic epitope of the 
-gliadin 33-mer. These antibodies were able to detect the presence of gliadin 33-mer-related 
epitopes in prolamins from wheat, barley, rye and various oats varieties (Morón et al., 2008a, 
b; Comino et al., 2011), and G12is a reliable tool for detecting oat varieties potentially safe 
for patients with celiac disease. These antibodies have proved to be very useful for the 
detection of toxic peptides in food samples and for the enzymatic detoxification of gluten in 
clinical research (Shan et al., 2002; Morón et al., 2008a; 2008b; Ehren et al., 2009).  
5.2.2. Techniques 
A standardised method of analysis is required to quantitatively determine the gluten content 
of food and provide the basis for enforcing regulations controlling the use of the term gluten 
free in food labelling. People with CD should feel confident that foods labelled gluten-free 
have been analysed for gluten using the the best available methodology.  
In January 2009, the European Commission published a new European Regulation concerning 
the composition and labelling of foodstuffs suitable for people intolerant to gluten; this 
regulation states that foods may display the term gluten-free if the gluten content does not 
exceed 20 mg/kg as sold to the final consumer (Commission of the European Communities, 
2009). Food containing between 20 ppm and 100 ppm of gluten is considered to be very low 
in gluten content according to the EU laws, but there is no full agreement among countries 
about the term gluten-free food. Consequently, methods for gluten analysis must be 
sensitive enough to quantify these levels of gluten in foods. 
5.2.2.1. Enzyme-linked immunosorbent assays (ELISAs) 
ELISAs have become the recommended methods in gluten analysis. Immunological methods 
are based on the antibodies raise against the different prolamin fractions or specific sequences 
found in prolamins. The requirement for the assays is that they should measure the harmful 
proteins and peptides, regardless of the type of food or manufacturing process (Denery-Papini 
et al., 1999). 
The sandwich R5 ELISA is the most common enzyme immunoassay formats used in 
detection of gluten proteins. It is highly sensitive and is especially useful for the 
quantification of antigens when their concentration is low, when they are contained in 
samples with a large amount of contaminating proteins, or both. This assay  uses two 
antibodies that bind to different sites on the antigen. Nowadays, it is the usual method for 
determining gluten content in gluten-free foods internationally accepted by the Codex 
Alimentarius Commission (Codex Alimentarius Commission, 2006) combined with what is 
known as the cocktail extraction solution. This ELISA is based on the R5 antibody and has a 
limit of quantification of 1.56 ppm of gliadins (Valdes et al., 2003). In hydrolysed foods the 
quantification of gluten by the sandwich R5 ELISA would yield lower values than the true 
gluten content.  
A sandwich ELISA using the monoclonal G12 and A1 antibodies gave very promising results 
for gluten analysis across a range of samples (Morón et al., 2008a; Halbmayr-Jech et al., 
2012). This method had a detection limit for wheat, barley, and rye prolamins of <1ppm. 
Furthermore, the reactivities of these antibodies were correlated with the potential 
immunotoxicity of those dietary grains from which the proteins were extracted, thereby 
providing a rational explanation for why some cereal varieties trigger immunological 
response, and enabling the presence of such varieties to be avoided in gluten-free diet 
(Comino et al., 2012 a).  
The competitive R5 ELISA, based on the R5 monoclonal antibody, leads to an accurate 
quantification of both intact and fragmented gluten because it uses only one antibody and 
requires only one epitope. In addition, the competitive system is cheaper and faster than the 
sandwich system ELISA (Mena et al., 2012). The Codex Alimentarius Commission states that 
a modification of the R5 assay (competitive ELISA) has to be applied for the detection of 
hydrolysed gluten (Codex Alimentarius Commission, 2006). However, the Food and Drug 
Administration (FDA) comments that analysts should be free to use any method that provides 
comparable results and that other methods may be equivalent. Another comment urged FDA 
to remain flexible as to the method of test validation and added that not specifying analytical 
methods would permit a more rapid development of dependable and affordable technologies 
for testing gluten (Federal Register / Vol. 78, No. 150 / Monday, August 5, 2013 / Rules and 
Regulations).  
The competitive technique is not compatible with the cocktail extraction solution, but the 
combination of this technique with the UPEX solution leads to complete gluten analysis. The 
limits of detection and quantification of the competitive R5 ELISA are 0.36 and 1.22 ng/ml of 
gliadins, respectively, being lower in liquid samples. Recently, a collaborative study has 
confirmed that the two R5 antibody-based ELISA test kits are able to detect gliadin at the 
lower level of the limit of detection with good reproducibility and repeatability (Immer and 
Haas-Lauterbach, 2012). 
A competitive ELISA method was also developed for the detection of toxic gluten peptides in 
hydrolysed foods based on G12 antibody. This assay is highly sensitive and reproducible with 
a detection limit of 0.44 ppm gliadin. This ELISA system showed high reproducibility and 
repeatability (Morón et al., 2008b; Ehren et al., 2009). 
5.2.2.2. Western blot  
Single and two-dimensional gel electrophoresis (both SDS-PAGE and A-PAGE) have been 
employed by different authors in order to characterise wheat, barley and rye proteins (Shuaib 
et al., 2007; Salmanowicz and Nowak, 2009). Nevertheless, these techniques have not enough 
sensibility for quantifying gluten in gluten free foods. In order to solve this problem, the 
separated proteins after one-dimensional SDS-PAGE  are electrotransferred onto a 
polyvinylidene difluoride membrane where the proteins are adsorbed. A specific antibody is 
the added, such as the R5 antibody (Garcia et al., 2005), G12 antibody (Morón et al., 2008a, 
b) or anti cells T gliadin alpha-20 antibody (van den Broeck et al., 2009). These 
immunological western blot techniques can be used for the confirmation of gluten content in 
foods.  
5.3. Non-immunological techniques 
The quantitative analysis of prolamins is mainly based on immunological methods, but mass 
spectrometric and chromatographic techniques have also been used (Wieser et al., 1998; 
Sealy-Voyksner et al., 2010). The use of complementary and alternative non-immunological 
systems to confirm the results of the immunological methods is very important especially in 
certain complex foods.  
5.3.1. Proteomic techniques 
Applying proteomics to this field is of great interest to complement other techniques but the 
analysis of gluten-free foods, where gluten proteins are in low amount comparing with the 
other major proteins presents more difficulties (Mamone et al., 2011). Mass spectrometry 
(MS) is one of the more important physical methods used nowadays due to its high 
sensibility, for identification, characterisation and quantification of proteins and peptides. The 
bases of these methods are an ionisation of molecules to study, separation of ions in basis to 
their relation mass/charge and detection of the separated ions. Depending on the different 
method of ionisation, separation and detection, there are several MS techniques, used in 
different applications. MALDI-TOF MS was the first technique used to identify toxic 
prolamins involved in coeliac disease. Even though MALDI-TOF gluten analysis is very 
useful (Hernando et al., 2003), identifying gluten based on the analysis of intact proteins is 
not sufficient, due to extensive sequence similarities among gluten proteins; the results for 
hydrolysed gluten are also insufficiently accurate. For unambiguous gluten protein 
identification, a proteomic approach involving tandem mass spectrometry (MS/MS) or 
multistage MS experiments would be very promising.  
5.3.2. Quantitative real-time PCR (Q-PCR) 
Several polymerase chain reaction (PCR) based methods for the detection and quantification 
of DNA of gluten-containing cereals have been described, but there are very few studies of 
their application to the analysis of gluten in foods. Recently, a Q-PCR system for reliable and 
rapid quantification of wheat DNA in gluten-free foods and in raw materials has been 
developed based on the fluorescent dye SYBR Green I and a modified SDS/Guanidine
HCl/Proteinase K DNA extraction protocol. This is a highly specific and sensitive system 
with a quantification limit of 20 pg DNA/mg; thus it can be used as a non-immunological tool 
in order to confirm, by the DNA pathway, the presence of wheat in food not only for 
coeliacs but also for individuals with wheat allergy (Mujico et al., 2011). However, in very 
processed foods, such as those subjected to hydrolysis, this type of techniques are not 
appropriated as they cannot identify the hydrolysed DNA and there is not possible to establish 
a correlation between the amount of DNA and gluten. 
Other authors have developed a DNA-based allergen-multiplex ligation-dependent probe 
amplification method for the determination of gluten in foods which might constitute a 
complementary method to the traditional protein-based methods (Mustorp et al., 2011). 
Conclusions 
The pathologies associated with gluten have increased in recent years worldwide. Although 
epitopes that trigger the CD have been described in gliadins and glutenins, the majority of 
them reside in the gliadin fraction of gluten. Nature offers a variety of cereals that are free of 
toxicity for gluten intolerant individuals, which include rice, corn, sorghum, millet, teff, and 
possibly some specific wheat varieties. In addition, pseudocereals such as quinoa and 
amaranth are safe to be consumed by coeliacs. A current topic of debate is the potential 
toxicity of oats, although there is recent evidence that of toxicity of some oat some cultivars. 
The structural complexity and polymorphism of gliadin proteins make it difficult to identify 
varieties naturally devoid of toxicity or to develop such varieties through breedings. 
Simultaneous silencing of the full complement of gliadins results in effective reduction of the 
epitopes recognised by T cells in CD, which shows that it is possible to eliminate or reduce 
the toxicity of wheat. Flour from these varieties properly labeled, can serve as starting 
material for the production of staple foods not only for CD but also for all gluten-related 
allergies or intolerance. 
The development of gluten-free leavened products from gluten-free cereals is still a challenge 
for food technologist. Great advances have been made in assessing the impact of the flour 
functionality and properties on bread quality and in creating protein networks in gluten-free 
flours, as well as in determining the effects of processing in bread production. Nutrition is 
now becoming the focus of food technology research aimed at developing safe and 
nutritionally-balanced gluten free foods.  
Safety of gluten free foods can be only ensured by providing reliable methods of gluten 
detection and quantitation. The numerous gluten components released after processing make 
extraction efficiency and detection very difficult. There is currently an internationally 
accepted method for gluten determination, the competitive ELISA based on the R5 antibody, 
while some other antibodies such as the monoclonal G12 and A1 are also very effective for 
detecting the presence of epitopes related to the gliadin33-mer in prolamins. In addition, 
different immunological and non-immunological techniques are being applied to increase the 
sensitivity and provide supplementary information on gluten protein identification.   
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Figure Captions 
Figure 1. Pathologies associated with gluten. 
Figure 2. Taxonomy and basic characteristics of the prolamines of oats in relation with other 
cereals. A. Taxonomy of oats in relation with other cereals. B. Basic characteristics of the 
prolamins of wheat, oats, and rice. 
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